Paul George: Everything you need to know

Paul George

#8 PF

Philadelphia 76ers

Status

ACTIVE

STATS

Career Averages

PTS

REB

AST

BLK

STL

22.6

6.3

4.0

0.4

1.7

Year	GP	GS	MIN	PTS	REB	AST	BLK	STL	TO	DD2	TD3	3PM	3PA	3P%	2PM	2PA	2P%	FGM	FGA	FG%	FTM	FTA	FT%	OREB	DREB	PF	A/TO	+/-	TS%
2025-26	37	37	30.7	17.3	5.3	3.6	0.4	1.7	1.7	2	0	2.7	6.9	39.2%	3.4	7.0	48.4%	6.1	13.9	43.9%	2.5	3.0	82.0%	0.5	4.8	2.3	2.1	+89	57.0%
2024-25	41	41	32.5	16.2	5.3	4.3	0.5	1.8	2.6	3	0	2.3	6.5	35.8%	3.6	7.4	49.3%	6.0	13.9	43.0%	1.9	2.4	81.4%	0.6	4.8	2.5	1.7	-83	54.3%
2023-24	74	74	33.8	22.6	5.2	3.5	0.5	1.5	2.1	3	0	3.3	7.9	41.3%	4.6	8.8	52.3%	7.9	16.7	47.1%	3.6	3.9	90.7%	0.5	4.7	2.7	1.7	+461	61.3%
2022-23	56	56	34.6	23.8	6.1	5.1	0.4	1.5	3.1	8	1	2.8	7.6	37.1%	5.4	10.3	52.1%	8.2	17.9	45.7%	4.6	5.3	87.1%	0.8	5.3	2.8	1.6	+157	58.8%
2021-22	31	31	34.7	24.3	6.9	5.7	0.4	2.2	4.1	7	0	2.9	8.3	35.4%	5.7	12.2	46.7%	8.6	20.5	42.1%	4.1	4.8	85.8%	0.4	6.5	2.4	1.4	+92	53.8%
2020-21	54	54	33.7	23.3	6.6	5.2	0.4	1.1	3.3	9	0	3.2	7.7	41.1%	5.1	9.9	51.0%	8.2	17.6	46.7%	3.7	4.2	86.8%	0.8	5.8	2.4	1.6	+432	59.8%
2019-20	48	48	29.6	21.5	5.7	3.9	0.4	1.4	2.6	5	0	3.3	7.9	41.2%	3.9	8.4	46.4%	7.1	16.3	43.9%	4.0	4.5	87.6%	0.5	5.2	2.4	1.5	+258	58.9%
2018-19	77	77	36.9	28.0	8.2	4.1	0.4	2.2	2.7	24	1	3.8	9.8	38.6%	5.4	11.1	48.4%	9.2	21.0	43.8%	5.9	7.0	83.9%	1.4	6.8	2.8	1.6	+496	58.3%
2017-18	79	79	36.6	21.9	5.7	3.3	0.5	2.0	2.7	4	0	3.1	7.7	40.1%	4.2	9.3	45.4%	7.3	17.0	43.0%	4.3	5.2	82.2%	0.9	4.7	2.9	1.2	+226	57.0%
2016-17	75	75	35.9	23.7	6.6	3.3	0.4	1.6	2.9	0	0	2.6	6.6	39.4%	5.7	11.4	50.1%	8.3	18.0	46.2%	4.5	5.0	89.8%	0.8	5.8	2.7	1.1	+0	58.7%
2015-16	81	81	34.8	23.1	7.0	4.1	0.4	1.9	3.3	3	0	2.6	7.0	37.1%	4.9	10.9	44.7%	7.5	17.9	41.8%	5.6	6.5	86.0%	1.0	6.0	2.8	1.2	+0	55.7%
2014-15	6	0	15.2	8.8	3.7	1.0	0.2	0.8	2.0	0	0	1.5	3.7	40.9%	1.5	4.5	33.3%	3.0	8.2	36.7%	1.3	1.8	72.7%	0.7	3.0	1.8	0.5	+0	49.2%
2013-14	80	80	36.2	21.7	6.8	3.5	0.3	1.9	2.8	2	0	2.3	6.3	36.4%	4.9	10.8	45.8%	7.2	17.0	42.4%	5.0	5.8	86.4%	0.8	6.0	2.5	1.3	+0	55.5%
Career	739	733	34.4	22.6	6.3	4.0	0.4	1.7	2.8	70	2	2.9	7.5	38.8%	4.8	9.9	48.2%	7.7	17.4	44.1%	4.3	5.0	86.0%	0.8	5.5	2.6	1.4	+2128	57.6%

Career Averages

PTS

REB

AST

BLK

STL

23.6

7.4

4.3

0.5

1.5

Year	GP	GS	MIN	PTS	REB	AST	BLK	STL	TO	DD2	3PM	3PA	3P%	2PM	2PA	2P%	FGM	FGA	FG%	FTM	FTA	FT%	OREB	DREB	PF	A/TO	+/-	TS%
2025-26	8	8	35.8	17.4	3.9	3.0	0.4	1.3	1.9	0	3.3	5.8	56.5%	2.9	6.6	43.4%	6.1	12.4	49.5%	1.9	2.4	78.9%	0.3	3.6	2.3	1.6	-14	64.7%
2023-24	6	6	37.0	19.5	6.8	4.8	0.5	1.2	2.3	2	3.0	8.2	36.7%	3.5	7.7	45.7%	6.5	15.8	41.1%	3.5	4.2	84.0%	0.5	6.3	3.7	2.1	-27	55.2%
2020-21	19	19	40.8	26.9	9.6	5.4	0.5	1.0	3.5	10	2.7	8.0	33.6%	6.0	11.7	51.4%	8.7	19.7	44.1%	6.8	8.1	84.4%	0.9	8.7	3.1	1.5	+73	57.8%
2019-20	13	13	36.8	20.2	6.1	3.8	0.5	1.5	3.1	1	2.8	8.5	33.3%	3.9	8.5	46.4%	6.8	17.0	39.8%	3.8	4.2	90.9%	1.1	5.0	3.8	1.2	+29	53.6%
2018-19	5	5	40.8	28.6	8.6	3.6	0.2	1.4	4.2	2	3.0	9.4	31.9%	5.8	10.8	53.7%	8.8	20.2	43.6%	8.0	9.8	81.6%	1.2	7.4	4.2	0.9	+3	58.3%
2017-18	6	6	41.8	24.7	6.0	2.7	0.7	1.3	4.0	1	3.2	8.7	36.5%	5.0	11.3	44.1%	8.2	20.0	40.8%	5.2	6.0	86.1%	0.7	5.3	2.8	0.7	-22	54.5%
2016-17	4	4	43.0	28.0	8.8	7.3	0.5	1.8	3.3	0	4.5	10.5	42.9%	4.0	11.5	34.8%	8.5	22.0	38.6%	6.5	7.5	86.7%	1.3	7.5	3.3	2.2	+0	55.3%
2015-16	7	7	39.3	27.3	7.6	4.3	0.7	2.0	3.3	0	2.6	6.1	41.9%	5.4	11.4	47.5%	8.0	17.6	45.5%	8.7	9.1	95.3%	1.3	6.3	3.4	1.3	+0	63.2%
2013-14	19	19	41.1	22.6	7.6	3.8	0.4	2.2	2.6	0	2.7	6.8	40.3%	4.5	9.8	46.2%	7.3	16.6	43.8%	5.3	6.7	78.9%	0.7	6.9	2.9	1.5	+0	57.8%
Career	87	87	39.6	23.6	7.4	4.3	0.5	1.5	3.1	16	2.9	7.7	37.9%	4.7	9.9	47.2%	7.6	17.7	43.1%	5.5	6.4	84.8%	0.8	6.6	3.2	1.4	+42	57.6%

Regular Season
Date	Opp	Result	MIN	PTS	REB	AST	BLK	STL	TO	3PA	3PM	3P%	2PA	2PM	2P%	FGA	FGM	FG%	FTA	FTM	FT%	OREB	DREB	A/TO	+/-	PF	PER	TS%
4/10	IND	W 105-94	33	21	5	2	0	1	1	9	3	33.3%	10	6	60.0%	19	9	47.4%	1	0	0.0%	0	5	2.0	+7	2	15	54.0%
4/9	HOU	L 113-102	24	7	4	1	0	1	4	5	0	0.0%	3	2	66.7%	8	2	25.0%	4	3	75.0%	0	4	0.3	-15	2	5	35.9%
4/6	SAS	L 115-102	38	16	4	4	0	2	1	5	4	80.0%	10	1	10.0%	15	5	33.3%	4	2	50.0%	0	4	4.0	-6	4	10	47.7%
4/4	DET	L 116-93	28	20	5	4	0	2	3	5	3	60.0%	9	4	44.4%	14	7	50.0%	4	3	75.0%	1	4	1.3	-9	3	20	63.5%
4/3	MIN	W 115-103	38	23	6	6	1	4	6	7	3	42.9%	8	3	37.5%	15	6	40.0%	10	8	80.0%	1	5	1.0	+0	2	27	59.3%
4/1	WAS	W 153-131	30	39	5	6	0	3	0	12	6	50.0%	10	9	90.0%	22	15	68.2%	4	3	75.0%	0	5	0.0	+26	2	45	82.1%
3/30	MIA	L 119-109	34	19	4	2	0	1	1	11	4	36.4%	7	3	42.9%	18	7	38.9%	1	1	100.0%	1	3	2.0	-22	2	12	51.5%
3/28	CHA	W 118-114	36	26	13	2	1	4	3	11	4	36.4%	8	5	62.5%	19	9	47.4%	5	4	80.0%	1	12	0.7	-5	5	31	61.3%
3/25	CHI	W 157-137	26	28	6	4	1	4	0	13	6	46.2%	9	5	55.6%	22	11	50.0%	0	0	0.0%	2	4	0.0	+14	2	32	63.6%
1/29	SAC	W 113-111	36	15	2	5	0	2	1	4	1	25.0%	11	6	54.5%	15	7	46.7%	0	0	0.0%	0	2	5.0	+5	1	12	50.0%
1/27	MIL	W 139-122	32	32	5	5	0	2	1	15	9	60.0%	6	2	33.3%	21	11	52.4%	2	1	50.0%	0	5	5.0	+13	3	31	73.1%
1/24	NYK	L 112-109	32	9	6	2	0	2	1	3	0	0.0%	7	3	42.9%	10	3	30.0%	3	3	100.0%	1	5	2.0	-2	2	10	39.8%
1/22	HOU	W 128-122	36	10	6	4	1	3	1	5	2	40.0%	4	2	50.0%	9	4	44.4%	0	0	0.0%	0	6	4.0	-1	5	12	55.6%
1/16	CLE	L 117-115	30	14	4	5	0	2	1	6	2	33.3%	6	4	66.7%	12	6	50.0%	0	0	0.0%	0	4	5.0	+9	1	20	58.3%
1/14	CLE	L 133-107	29	17	4	4	0	1	0	4	2	50.0%	10	5	50.0%	14	7	50.0%	2	1	50.0%	0	4	0.0	-8	1	20	57.1%
1/12	TOR	W 115-102	28	15	4	6	0	0	1	6	1	16.7%	7	4	57.1%	13	5	38.5%	5	4	80.0%	0	4	6.0	+4	3	16	49.3%
1/9	ORL	W 103-91	33	18	9	3	2	3	3	7	0	0.0%	14	8	57.1%	21	8	38.1%	2	2	100.0%	5	4	1.0	+9	3	16	41.1%
1/7	WAS	W 131-110	32	23	4	5	1	2	1	8	4	50.0%	3	3	100.0%	11	7	63.6%	6	5	83.3%	0	4	5.0	+25	0	32	84.3%
1/5	DEN	L 125-124	32	8	2	3	1	2	0	7	2	28.6%	3	1	33.3%	10	3	30.0%	0	0	0.0%	0	2	0.0	-18	3	5	40.0%
1/3	NYK	W 130-119	35	15	8	6	2	0	1	5	3	60.0%	6	2	33.3%	11	5	45.5%	3	2	66.7%	2	6	6.0	+5	5	21	60.9%
1/1	DAL	W 123-108	33	14	7	2	0	1	5	3	0	0.0%	8	5	62.5%	11	5	45.5%	4	4	100.0%	1	6	0.4	+20	3	12	54.9%
12/30	MEM	W 139-136	39	17	3	3	0	0	3	11	3	27.3%	6	3	50.0%	17	6	35.3%	2	2	100.0%	0	3	1.0	+11	5	6	47.5%
12/28	OKC	L 129-104	29	12	4	3	0	1	3	7	4	57.1%	4	0	0.0%	11	4	36.4%	0	0	0.0%	0	4	1.0	-19	1	9	54.5%
12/26	CHI	L 109-102	34	15	11	5	0	0	1	9	4	44.4%	6	1	16.7%	15	5	33.3%	1	1	100.0%	1	10	5.0	-1	3	19	48.6%
12/23	BKN	L 114-106	33	19	4	2	2	4	3	7	2	28.6%	7	3	42.9%	14	5	35.7%	8	7	87.5%	0	4	0.7	+0	3	19	54.2%
12/19	NYK	W 116-107	33	7	6	4	0	1	1	6	1	16.7%	4	1	25.0%	10	2	20.0%	2	2	100.0%	0	6	4.0	+16	3	8	32.2%
12/14	ATL	L 120-117	33	35	4	3	1	0	2	10	7	70.0%	11	4	36.4%	21	11	52.4%	6	6	100.0%	0	4	1.5	+2	1	35	74.0%
12/12	IND	W 115-105	33	23	6	5	0	1	4	7	4	57.1%	10	4	40.0%	17	8	47.1%	3	3	100.0%	1	5	1.3	+19	2	23	62.8%
12/7	LAL	L 112-108	32	12	6	3	0	1	1	3	1	33.3%	5	2	40.0%	8	3	37.5%	5	5	100.0%	0	6	3.0	-12	3	17	58.8%
12/5	MIL	W 116-101	29	20	5	5	0	1	0	6	2	33.3%	9	5	55.6%	15	7	46.7%	4	4	100.0%	0	5	0.0	+7	2	26	59.7%
12/2	WAS	W 121-102	17	11	5	0	0	1	2	5	3	60.0%	5	1	20.0%	10	4	40.0%	0	0	0.0%	0	5	0.0	+6	1	8	55.0%
11/30	ATL	L 142-134	28	16	7	4	0	5	1	8	2	25.0%	9	4	44.4%	17	6	35.3%	2	2	100.0%	2	5	4.0	+1	4	18	44.7%
11/28	BKN	W 115-103	21	14	3	2	0	2	1	5	2	40.0%	5	4	80.0%	10	6	60.0%	0	0	0.0%	0	3	2.0	+9	0	16	70.0%
11/23	MIA	L 127-117	20	10	2	5	1	1	2	5	0	0.0%	5	3	60.0%	10	3	30.0%	5	4	80.0%	1	1	2.5	+3	2	9	41.0%
11/20	MIL	W 123-114	24	21	5	3	0	2	3	7	4	57.1%	5	3	60.0%	12	7	58.3%	4	3	75.0%	0	5	1.0	+3	0	24	76.3%
11/17	LAC	W 110-108	21	9	7	3	2	0	1	4	1	25.0%	5	1	20.0%	9	2	22.2%	7	4	57.1%	0	7	3.0	-9	0	14	37.3%
Regular Season Totals			30.9	17.5	5.3	3.6	0.4	1.7	1.8	7.0	2.8	39.4%	7.1	3.4	47.8%	14.1	6.1	43.7%	3.0	2.5	81.7%	0.6	4.8	2.1	+87	2.3	21.0	56.9%

Postseason
Date	Opp	Result	MIN	PTS	REB	AST	BLK	STL	TO	3PA	3PM	3P%	2PA	2PM	2P%	FGA	FGM	FG%	FTA	FTM	FT%	OREB	DREB	A/TO	+/-	PF	PER	TS%
5/4	NYK	L 137-98	26	17	3	3	0	0	1	6	4	66.7%	5	2	40.0%	11	6	54.5%	1	1	100.0%	0	3	3.0	-26	1	17	74.3%
5/2	BOS	W 109-100	41	13	3	1	0	0	3	5	3	60.0%	5	2	40.0%	10	5	50.0%	0	0	0.0%	0	3	0.3	+9	4	5	65.0%
4/30	BOS	W 106-93	39	23	4	3	1	2	4	9	5	55.6%	8	3	37.5%	17	8	47.1%	2	2	100.0%	0	4	0.8	+11	2	22	64.3%
4/28	BOS	W 113-97	43	16	9	7	0	2	2	9	4	44.4%	4	2	50.0%	13	6	46.2%	0	0	0.0%	0	9	3.5	+19	5	21	61.5%
4/26	BOS	L 128-96	30	16	4	1	1	3	1	3	3	100.0%	10	3	30.0%	13	6	46.2%	1	1	100.0%	1	3	1.0	-13	1	16	59.5%
4/24	BOS	L 108-100	41	18	0	5	0	2	1	7	4	57.1%	7	3	42.9%	14	7	50.0%	0	0	0.0%	0	0	5.0	-4	1	17	64.3%
4/21	BOS	W 111-97	35	19	4	3	1	1	1	5	2	40.0%	8	5	62.5%	13	7	53.8%	6	3	50.0%	1	3	3.0	+0	3	20	60.7%
4/19	BOS	L 123-91	28	17	4	1	0	0	2	2	1	50.0%	6	3	50.0%	8	4	50.0%	9	8	88.9%	0	4	0.5	-10	1	19	71.1%
Postseason Totals			35.8	17.4	3.9	3.0	0.4	1.3	1.9	5.8	3.3	56.5%	6.6	2.9	43.4%	12.4	6.1	49.5%	2.4	1.9	78.9%	0.3	3.6	1.6	-14	2.3	20.1	64.7%

Paul George: Breaking News

George supplied 17 points (6-11 FG, 4-6 3Pt, 1-1 FT), three rebounds and three assists across 26 minutes in Monday's 137-98 loss to the Knicks in Game 1 of the Eastern Conference Semifinals. George turned in an efficient performance Monday, knocking down a game-high four triples while leading Philadelphia in scoring despite a blowout loss that kept him off the floor in the fourth quarter. The veteran forward also paced the first unit in assists. He has now hit at least three three-pointers in six straight games, scoring 16-plus points in five of them. George will look to remain productive in Game 2 on Wednesday as the Sixers try to steal a game at Madison Square Garden.

George (illness) will play in Saturday's Game 7 of the Eastern Conference first-round series against the Celtics, Adam Aaronson of PhillyVoice.com reports. George was a late addition to the injury report due to an illness, though he'll give it a go in this win-or-go-home matchup. Through six first-round outings, the star forward has averaged 18.2 points, 4.2 rebounds, 3.3 assists and 1.7 steals in 36.3 minutes per contest.

George is listed as probable for Game 7 of the first round of the Eastern Conference playoffs against the Celtics on Saturday due to an illness, Derek Bodner of AllPHLY.com reports. George played a key role in the Sixers' Game 6 win on Thursday, when he logged 23 points, four rebounds, three assists, two steals and one block over 40 minutes. Given that Saturday is an elimination game, George will likely try and play through his ailment, though he could be facing a reduced workload if his condition worsens over the course of the day. If that were to be the case, then Justin Edwards and Kelly Oubre would step into larger roles for the Sixers behind the superstar duo of Joel Embiid (abdomen) and Tyrese Maxey.